All In Biotech

Free tool

FAERS Monitor: Nulojix

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125288 or its brand name (Nulojix, Belatacept). Reports on generic versions are filed under their own applications.

Reports

4,739

Serious

3,595

76% of reports

Hospitalization

1,797

Death reported

750

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use463
  • death232
  • transplant rejection231
  • kidney transplant rejection222
  • drug ineffective196
  • cytomegalovirus infection179
  • acute kidney injury178
  • product storage error177
  • covid-19149
  • hospitalisation128
  • pyrexia117
  • thrombotic microangiopathy105
  • diarrhoea101
  • urinary tract infection97
  • post transplant lymphoproliferative disorder95

Reports by year received

View as table
YearReports
20053
20061
20073
200813
200937
201030
201165
2012106
2013231
2014183
2015174
2016246
2017264
2018298
2019265
2020383
2021394
2022372
2023530
2024449
2025460
2026232

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,420 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
kidney transplant rejectionSignal222215.3188.744,961
transplant rejectionSignal231131.7115.928,983
post transplant lymphoproliferative disorderSignal9584.469.07,603
thrombotic microangiopathySignal10548.340.04,770
cytomegalovirus infectionSignal17948.341.88,164
product storage errorSignal1779.07.81,252
acute kidney injurySignal1785.24.5598
covid-19Signal1493.83.2303
hospitalisationSignal1283.73.1251
urinary tract infectionSignal972.52.188
off label useSignal4632.32.2372
pyrexia1171.51.319
death2321.21.18
diarrhoea1010.70.614
drug ineffective1960.70.636

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.